3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
14
Completed
12
Terminated
7
Active not recruiting
4
Withdrawn
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myelodysplastic Syndromes
92
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Leukemia, Myeloid, Acute
79
Leukemia
41
Myeloproliferative Disorders
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Multiple Myeloma
21
Leukemia, Myeloid, Chronic-Phase
20
Lymphoma, Non-Hodgkin
18
Lymphoma
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Leukemia, Myelomonocytic, Chronic
16
Polycythemia Vera
14
Hodgkin Disease
14
Primary Myelofibrosis
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms, Plasma Cell
10
Lymphoma, Follicular
10
Hematologic Neoplasms
10
Burkitt Lymphoma
10
Recurrence
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Anemia, Refractory, with Excess of Blasts
9
Myelodysplastic-Myeloproliferative Diseases
8
Mastocytosis, Systemic
8
Mastocytosis
8
Lymphoma, Mantle-Cell
8
Lymphoma, Large-Cell, Immunoblastic
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Accelerated Phase
8
Interventions
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Blastic Plasmacytoid Dendritic Cell Neoplasm
×
Myeloid
×
Clear all
NCT03599960
2024-02-08
LpDessai
Centre Hospitalier Universitaire de Besancon
Phase 2
Unknown
26 enrolled